Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Imo this is under valued. They are putting things together so the big picture will be revealed soon. Almost all the yearly charts look quite simular (trending down since June, July last year then running sideways on the bottom). This should easily rebound once the market reflects confidence. Patience will pay off for sure, personally I think this should be running sideways at .03 - .035 range. Haven't seen huge sell offs on news so that's a plus GLTA
$NASV
They have a lot of things in motion, 1/2 billion share reduction, hive app, just to name a couple. The potential growth is here at this pps it's a steal. IMO we've seen the bottom
This came in my E*Trade portfolio news feed under $SCIE seems to me it's been halted (along with a few other tickers) to protect hedge funds with large short positions.
UPDATE 4-Cannabis stocks chill after red-hot rally
12:48 PM ET 2/11/21 | Reuters
UPDATE 4-Cannabis stocks chill after red-hot rally
* U.S.-listed Tilray, Sundial highly touted on Reddit
* Reddit-fuelled trading had squeezed GameStop 'shorts'
* European retail traders pile into U.S.-led trading rally
* Harris flagged Biden push to decriminalise marijuana (Updates prices, adds SEC statement on social media trading, short interest data)
By Danilo Masoni, Julien Ponthus and Chuck Mikolajczak
Feb 11 (Reuters) - Shares in some cannabis firms cooled off on Thursday, after Reddit-inspired retail investors swarmed to the stocks in the latest bet to beat short-sellers and benefit from new legislation that is expected under U.S. President Joe Biden.
After climbing in premarket trading as European retail investors piled in to the rally, U.S.-listed shares of Tilray and Aphria, the two biggest holdings in the ETFMG Alternative Harvest ETF, tumbled 39.40% and 28.33%, respectively. Tilray had soared more than 148% while Aphria has surged nearly 58% this week through Wednesday's close.
Shares in Sundial Growers, up 46% through Wednesday, also turned lower and were last down 11.57%. The stock was the most actively traded across all U.S. exchanges with nearly 1.9 billion shares traded.
"With cannabis stocks you have the new administration and the potential for legislation, a real fundamental item... to the extent that if there is a big change in some of those laws, it would be very favorable for those companies," said Tom Martin, senior portfolio manager at Globalt Investments in Atlanta.
"But I would caution that that legislation is still a ways away and there are other more pressing items in front of legislators at this point such as COVID-19."
Participants on the WallStreetBets forum on Reddit, which inspired a price spike in GameStop earlier this year that squeezed out Wall Street short-sellers who had bet on a price fall, have turned attention to U.S. and Canadian cannabis firms.
"The involvement of Reddit means a frenzy is the right word," said Jasper Lawler, head of research at London Capital Group in London.
"I’m splitting the outlook in two. Reddit targeting a short-squeeze in Tilray means a quick pump and dump," he said, while others looked longer-term at benefits from potential legislative changes under Biden and his Democrat allies in Congress.
U.S. Vice President Kamala Harris said in the presidential campaign marijuana would be decriminalised at a federal level in the United States under a Biden administration.
Swaggystocks, which aggregates sentiment on shares discussed on WallStreetBets which has about 8 million participants, showed Sundial and Tilray were the most or highly touted stocks.
According to research firm S3 Partners, short interest in the nearly 200 cannabis stocks in the United States and Canada is $4.95 billion and is highly concentrated in a few names, with "short interest of the top twenty most shorted stocks in the sector at $4.86 billion."
Short interest in Tilray, measuring the number of shares borrowed by short sellers betting on a price fall, was about 37% on Wednesday compared to 27% at the end of January, financial analytics firm Ortex said.
S3 noted that while Canopy Growth was the largest short in the sector, Tilray "has closed the gap significantly."
Short-sellers borrow stocks and sell them on, aiming to buy them back later more cheaply and pocket the difference. If the shares move up instead, they face a 'short squeeze' as they race to buy the stock to close out their positions to stem losses.
Along with Sundial, other pot stocks such as Aurora Cannabis , were also among the most actively traded in the United States.
The recent surge of activity in stocks spurred by social media has caught the attention of the U.S. Securities and Exchange Commission, which announced on Thursday that it suspended trading in "an inactive company amid questions surrounding online promotion of the company’s securities and recent trading activity."
The order, for the over-the-counter traded SpectraScience , notes there may be a coordinated attempt by certain social media accounts to artificially influence the stock price.
Customers on eToro, a retail trading platform seen as an alternative in Europe to popular U.S. platforms such as Robinhood, opened more positions in Tilray on Wednesday than in the first 10 months of 2020 combined.
One eToro user in Germany, @ChrisBro14, wrote in a thread about Tilray as it traded around $70: "Guess will go to $100. Where do you have TP limit. What do you think it will (do)?"
Interest in the sector lifted cannabis-focused exchange traded funds (ETFs) to new highs, with some more than doubling in value over the past month.
(Reporting by Chuck Mikolajczak in New York, Danilo Masoni in MILAN and Julien Ponthus in LONDON; Shreyashi Sanyal and Medha Singh in BANGALORE; Editing by Edmund Blair and Lisa Shumaker)
That's okay..Just stay focused this is a company on the right path. Doing good business the share price will reflect that no games can change that. IMO
Buying dips strong hands.
$$TSNP $$
I did look into it myself but couldn't find any clear cut information one way or the other. I did find a link that has a couple of his affiliates who will probably take the lead to see the merger through IMO.
https://www.marketscreener.com/business-leaders/Joseph-Arcaro-0LPW41-E/biography/
$JADA
Good things coming for HUMBL
https://www.benzinga.com/stock/tsnp
See press release
$TSNP
HUMBL Completes Merger with Tesoro Enterprises, Inc.; Sells Warrants with Provision for $50 Million In Funding
9:00 AM ET 12/9/20 | GlobeNewswire
HUMBL Completes Merger with Tesoro Enterprises, Inc.; Sells Warrants with Provision for $50 Million In Funding
San Diego, California, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Tesoro Enterprises, Inc. (OTCMKT: TSNP) announced today that its merger with HUMBL, LLC is complete, and the company is now a registered Delaware corporation. Additional amendments are now being filed with the Delaware Secretary of State's office to change the name of the corporation to "HUMBL, Inc." Furthermore, corporate actions are being prepared for filing with the Financial Industry Regulatory Authority ("FINRA") to have the public entity renamed "HUMBL, Inc." together with a request for a change in the ticker symbol to "HMBL".
HUMBL celebrated the merger by launching its new landing page at www.HUMBLpay.com, which premiers the company's brand video - "A Borderless Day in Baja." The video has received overwhelming response in previews to industry professionals and HUMBL partners.
As a result of the completion of the merger, HUMBL was able to consummate November 23, 2020 agreements to raise funding through the cash sale of warrants. As these warrants are exercised, HUMBL will access up to $50 million in equity funding, to be used for marketing of the HUMBL global brand; the HUMBL(R) mobile app and HUMBL Hubs(R) merchant software; as well as distribution and partnerships around the world.
Shares acquired through the exercising of the warrants will not be saleable through the retail market for a period of one year from the purchase date of the warrants.
About HUMBL, Inc.
The mission of HUMBL(R) and HUMBL Hubs(TM) is to deliver high quality, low cost digital payments and financial services. The HUMBL network was designed to support vertical markets such as government, banking, wireless and merchants in locations like Latin America, Caribbean, Asia and Africa who are seeking to migrate to digital payment and financial technologies, to help reduce costs and improve settlement speeds for customers.
The HUMBL(R) Mobile App delivers borderless transactions, by integrating multiple currencies, payment methods, banks, blockchain and financial services providers into one-click for the customer. HUMBL(R) provides greater access and portability than US only mobile wallet providers, such as Venmo(R) and Zelle(R) and will offer a HUMBL Hubs(TM) merchant software for clients without smartphones in certain domiciles.
"We aren't building HUMBL for the 350 million customers using PayPal(R) , but for the 7 billion people for whom money moves in different pathways, formats and cost structures," according to the CEO of HUMBL, Brian Foote.
The HUMBL website features global brand videos, product tours, market research, white papers and network architecture at www.HUMBLpay.com.
Safe Harbor Statement
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by the use of the words "may," "will," "should," "plans, " "expects," "anticipates," "continue," "estimates," "projects," "intends," and similar expressions. Forward-looking statements involve risks and uncertainties that could cause results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, the Company's ability to successfully execute its expanded business strategy, including by entering into definitive agreements with suppliers, commercial partners and customers; general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technical advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, regulatory requirements and the ability to meet them, government agency rules and changes, and various other factors beyond the Company's control.
CONTACT:
HUMBL, LLC
investors@HUMBLpay.com
Attachment
-- Tesoro Enterprises, Inc.
$$TSNP
Lot of things going on. Should get interesting around here soon
https://microcapdaily.com/ppe-non-toxic-sanitization-the-run-on-optec-international-inc-otcmkts-opti/129034/
Let's rock!!
$OPTI
Just a reminder we have a lot to look forward to
https://www.accesswire.com/601787/Anthea-Inc-FY2020-Outlook
$CLSI (Obocon Inc.)
My take on the $OPTI Stock Day podcast the $2 billion contract didn't include any UV products..how big is that!!! That means we're just scratching the surface?
$OPTI
Jolly then asked for more details about the Company’s $2 billion PPE order. “We’re not at this point going to be able to release the name, but it is an international commodities entity,” shared Pawson. “We’ve been working on fulfillment almost immediately,” he said. “From a profitability standpoint, obviously it’s profitable for the company. We can’t divulge the percentage at this point, for obvious reasons, but of course it will show in the December 31st quarterly report,” continued Pawson. “We’re really happy with it. There’s a huge logistics operation attached to that.”
Pawson then elaborated on the PPE order and the type of product it includes. “What I can tell you is that it’s related to the medical industry during the pandemic – it’s face masks, gowns, and hospital-grade gloves, as well as hospital-grade sterilization wipes,” said Pawson. “The logistics I expect from this single order is almost 1,000 53-foot trailers. So, it’s a huge operation.”
Obviously you don't know enough Africa is a continent, with many thriving countries from Libya, Egypt,Ghana just to name a few. It's rich in natural resources and let's not forget the group of countries there where going to use gold for it currency (change the world) plenty of money there. Some of the most beautiful places on earth as well.
$ALYI
Bottom line this is definitely worth more than its current pps. This will without a doubt see silver in due time imo.
Go $BBRW
Blackhawk Granted Rights to Distribute Emergency Use Authorized PCR Test Kit and Additional Emergency Use Authorized Covid-19 Antibody Test
8:31 AM ET 9/3/20 | Dow Jones
Blackhawk Granted Rights to Distribute Emergency Use Authorized PCR Test Kit and Additional Emergency Use Authorized Covid-19 Antibody Test
September 03, 2020 -- (Blackhawk Growth Corp.) --
(TheNewswire)Vancouver, British Columbia - TheNewswire - September 3, 2020 - Blackhawk Growth Corp. (CSE:BLR) (CNSX:BLR.CN) (OTC:BLRZF) (the "Corporation" or "Blackhawk"), is pleased to announce that it has entered into a definitive distribution agreement (the "Distribution Agreement"), dated effective August 31, 2020, with Medigen Biotechnology Corporation ("MBC")its affiliate company, TBG Biotechnology Corp. ("TBG") and a local agent, Boshic Advanced Materials Co., Ltd. ("Boshic") to distribute certain diagnostic products, including an ExProbe SARS-CoV-2 Testing Kit and a SARS-CoV-2 IgG/IgM Rapid Test Kit (collectively, the "Test Kits") used in the detection of antibodies associated with COVID-19. The Distribution Agreement replaces the memorandum of understanding entered into between Blackhawk, MBC and TBG, dated effective August 3, 2020.
About the ExProbe SARS-CoV-2 Testing Kit Click Image To View Full Size
About the SARS-CoV-2 IgG/IgM Rapid Test Kit Click Image To View Full Size
*taken from TBG's corporate presentation
The Distribution Agreement grants Blackhawk the non-exclusive right to distribute the Test Kits in North and South America, including Canada and the United States. The ExProbe SARS-CoV-2 Testing Kit has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for use in the United States by authorized laboratories, as of June 10, 2020, and the SARS-CoV-2 IgG/IgM Rapid Test Kit has received Emergency Use Authorization from the FDA on August 31st, 2020.
While sale of both the ExProbe SARS-CoV-2 Testing Kit as well as the SARS-CoV-2 IgG/IgM Rapid Test Kit are permitted in the United States, neither of the Test Kits have been approved by Health Canada. Blackhawk intends to submit the Test Kits for Health Canada approval. Both MBC and TBG have committed to supporting Blackhawk's efforts to obtain and maintain all necessary certifications and approvals for the sale and marketing of the Test Kits in Canada by granting access to all necessary documentation and studies concerning the Test Kits. Once Health Canada approval is granted, Blackhawk would be the exclusive and sole distributor in Canada provided minimum order and sales levels are maintained.
There can be no guarantee that Health Canada approval will be received once an application is completed.
In consideration for the ongoing rights to distribute the Test Kits, Blackhawk will use its best efforts to achieve certifications and licenses for the distribution of the Test Kits in Canada and South America and has agreed not to distribute any other COVID-19 rapid antibody test products in North and South America. Blackhawk is also required to maintain certain minimum sales levels in order to retain rights under the Distribution Agreement, which include purchasing at least 50,000 Test Kits within the initial three months of the Distribution Agreement and purchasing at least 200,000 Test Kits within six months. Failure to achieve minimum sales levels could result in the termination of the Distribution Agreement, and the loss of all rights to distribute the Test Kits. No cash will be paid, or securities issued, in consideration for the grant of the distribution rights.
The Corporation is at arm's length from both MBC, TBG and Boshic. The grant of the distribution rights to the Test Kits neither constitutes a fundamental change or change of business for the Corporation, nor will it result in a change of control of the Corporation within the meaning of applicable securities laws and the policies of the Canadian Securities Exchange. No securities of the Corporation will be issued in connection with the transactions contemplated by the Distribution Agreement.
Readers are cautioned that the Corporation has not independently verified testing statistics and data provided by MBC and TBG. The Corporation has not received any assurances as to the timeline for the manufacturing and distribution of the Test Kits in North and South American, or as to the capacity of MBC and TBG to produce a sufficient volume of the Test Kits to make distribution economically feasible.
"I am excited to announce the closing of this deal" says Frederick Pels, CEO of Blackhawk. "We wanted to negotiate more than just a deal, but a true partnership and I am certain we achieved that here. I look forward to working with TBG, Medigen and Boshic to provide an extremely needed and superior quality product. We combed through every detail to ensure a harmonious and effective deal that separates us from the pack and I anticipate the relationship to grow substantially over the coming months and look forward to updating our shareholders with our upcoming initiatives."
"We are pleased indeed to collaborate with such a motivated and committed company as Blackhawk" says Stanley Chang, Chairman of Medigen and TBG. "We are engaged in the business of in vitro diagnostic test for the past 20 years, and facing COVID-19 pandemic, we provided comprehensive testing solutions and products of high quality. Joining our strength together with Blackhawk and Boshic, we expected to see the business of our Test Kits flourishing in North and South America and help more people fighting against COVID-19 pandemic."
About Medigen Biotechnology Corp.
Established in late 1999, Medigen Biotechnology Corp. (MBC) is a publicly traded company listed on the Taiwanese Stock Exchange. The company upholds the vision of "Innovations for a better life" focusing on the development of new therapies for liver diseases and cancers.
MBC has now developed into a comprehensive biopharmaceutical corporation with business fields covering new drug development, innovative drug discovery, molecular diagnostics, vaccine, and generic drugs. Combining Taiwan's biomedical research capabilities, international clinical development experiences and competitiveness in commercialization of state-of-the-art technologies, Medigen has built up a portfolio of patent protected projects which will be transformed into products approved by the regulatory bodies of various countries. For more information on Medigen, please visit their website here: http://www.medigen.com.tw/en/home/
About TBG Biotechnology Corp.
TBG Biotechnology Corp. (TBG) is a global molecular diagnostics company dedicated to the development, manufacture and marketing of molecular diagnostics kits, instruments and services. With its research and development based in the US, Taiwan and China, TBG manufactures its products in its ISO13485 certified facility in Xiamen, China serving the clinical labs of both hospitals and independent reference labs, blood centers and bone marrow registry labs around the world.
For more information on TBG, please visit their website here: http://www.tbgbio.com/en
For further information please contact:
Frederick Pels, Chief Executive Officer
(403)-991-7737
fred@blackhawkgrowth.com
Cautionary Note Regarding Forward-Looking Statement
All statements in this press release, other than statements of historical fact, are "forward-looking information" with respect to the Corporation within the meaning of applicable securities laws, including with respect to completion of the acquisition of the distribution rights for the Test Kits, the approval of the Test Kits by the United States Food and Drug Administration, and Health Canada, and the marketing and distribution of the Test Kits in North and South America. The Corporation provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited those identified and reported in the Corporation's public filings under the Corporation's SEDAR profile at www.sedar.com. Although the Corporation has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. The Corporation disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.
Copyright (c) 2020 TheNewswire - All rights reserved.
> Dow Jones Newswires
September 03, 2020 08:31 ET (12:31 GMT)
Brewbilt Mfg. $BBRW Massive Exposure Coming, To Be Featured On Jim Cramer's CNBC "Mad Money" Segment Next Week predicts RMB
https://t.co/BnESoqsmxY
BREWBILT MFG $BBRW Share Price To Rise As Zach's Raises Short Term Price Target predicts RMB
https://t.co/BnESoqsmxY
$BBRW
Rumor has it they're going to be on a segment of Jim Cramer's Mad Money next week. This will bring great exposure
$BBRW
Have to put in ($jada stock) to get to it..
$JADA
Well for sure Medicaid and Medicare pays 100% in most cases especially for children who will benefit most from this technology.
Does anyone know anything about this?
Cat-like grace_Arrayit Corporation $ARYC To Receive Upfront Cash Payment Following Merger & Acquisition Talks In Denver, PR Coming
https://t.co/Da6kuKbajf
Does anyone know what this is?
Happy As A Clam_Arrayit Corporation $ARYC CEO To Confirm Reverse Merger Discussions Underway In New York City
https://t.co/TrP59j8jeH
I agree with you. Got in at .0001 back in March, sold at .0006 and .0019 made 5x my investment now sitting on millions of freebies. More to come imo, not going anywhere until it hits copper.
$nouv
I have E-Trade and been sitting on this for about a year..no problems
Check out @CaliPharms’s Tweet: https://twitter.com/CaliPharms/status/1060755268437344256?s=09
The REAL DEAL!!! Getting more shares at every opportunity.
$ARYC
J.G. Wentworth® Partners with Homes For Our Troops to Build and Donate Specially Adapted, Custom Home for Injured Pennsylvania Veteran https://seekingalpha.com/article/17048090?source=ansh $JGWEQ
Does a shareholder lose all of their equity once a Chapter 11 bankruptcy is filed by the company?
By Chizoba Morah
SHARE
A:
When a company files for Chapter 11 bankruptcy, the management of the company is still in charge of the daily operations. That said, significant business decisions, especially those pertaining to debt or debt securities, are sent to the bankruptcy court for approval. While the firm is in Chapter 11, its stock will still have value, but there is a temporary trading freeze. Although the stock will be delisted, over the counter (OTC) trading may still occur. In other words, the equity a broker has invested in the firm is not valued at zero, but their true value cannot be easily determined since the shares are no longer publicly traded.
If the company proceeds to file for Chapter 7 bankruptcy, the company's creditors are paid in a specific order. Generally, investors or creditors are paid in the following order:
1) Secured creditors
2) Unsecured creditors
3) Shareholders
Usually, little to nothing is leftover for shareholders after the more senior creditors are paid. However, if the company restructures and emerges from Chapter 11 as an improved organization, its share price may rise to higher levels than previously witnessed.
When a corporation is on the verge of bankruptcy, its stock value will reflect the risk that a Chapter 11 may become a Chapter 7. For example, a company traded at $50 may trade at $2 per share due to bankruptcy speculation. If Chapter 11 is actually filed, the stock price may fall to 10 cents. This value is composed of the potential income that shareholders may receive after liquidation and a premium based on the possibility that the firm may restructure and begin to operate successfully in the future. Private investors can buy and sell these 10-cent shares in the OTC market. The actual value does not reach zero unless the probability of restructuring is so low that a Chapter 7 filing is sure to follow.
For more, check out What are the differences between Chapter 7 and Chapter 11 bankruptcy?
This question was answered by Chizoba Morah.
RELATED FAQS
What are the differences between Chapter 11 and Chapter 13 bankruptcy?
Discover the differences, including respective advantages and disadvantages, between Chapter 11 bankruptcy and Chapter 13 ... Read Answer >>
What happens when a corporation declares bankruptcy?
Understand what options are available to corporations under bankruptcy protection, and learn what takes place after bankruptcy ... Read Answer >>
What happens to a company's stocks and bonds when it declares chapter 11 bankruptcy ...
Filing for chapter 11 bankruptcy protection simply means that a company is on the verge of bankruptcy, but believes that ... Read Answer >>
What happens to the shares of a company that has been liquidated?
Learn what happens to a company's shares during Chapter 11 and Chapter 7 bankruptcy proceedings, and understand how much ... Read Answer >>
RELATED ARTICLES
Bankruptcy Filing Changes That Could Affect You
SPONSORED CONTENT
Back-Tested Strategies: Real or Random?
BY VANGUARD
File Chapter 7 Bankruptcy
Your Guide To Chapter 7 Bankruptcy
When To Declare Bankruptcy
How To Survive A Bankruptcy Filing
Changing The Face Of Bankruptcy
How to Hire a Bankruptcy Lawyer
Worst Case Scenario For Credit Card Debt
Don't Go Broke Buying Bankrupt Stocks
RELATED TERMS
Chapter 10
Chapter 7
Bankruptcy Abuse Prevention And Consumer Protection Act - BAPCPA
Chapter 15
IRS Publication 908
Chapter 13
WORK WITH INVESTOPEDIA
About Us Advertise With Us Contact Us Careers
© 2017, Investopedia, LLC.
Feedback All Rights Reserved Terms Of Use Privacy Policy
Read more: Does a shareholder lose all of their equity once a Chapter 11 bankruptcy is filed by the company? https://www.investopedia.com/ask/answers/10/stock-holder-lose-equity-chapter-11.asp#ixzz51IU3ku7g
Follow us: Investopedia on Facebook
Check Market Wire